4.7 Article

Optical Barcoding for Single-Clone Tracking to Study Tumor Heterogeneity

期刊

MOLECULAR THERAPY
卷 25, 期 3, 页码 621-633

出版社

CELL PRESS
DOI: 10.1016/j.ymthe.2016.12.014

关键词

-

资金

  1. German Federal Ministry of Education and Research (BMBF) (project SYS-GLIO) [031A425C]
  2. Anni Hofmann Stiftung
  3. German Research Foundation (DFG) [SFB841/SP2]
  4. Georg und Jurgen Rickertsen-Stiftung
  5. Johannes-Bauer Stiftung
  6. FFM grant from University Medical Center Hamburg-Eppendorf

向作者/读者索取更多资源

Intratumoral heterogeneity has been identified as one of the strongest drivers of treatment resistance and tumor recurrence. Therefore, investigating the complex clonal architecture of tumors over time has become a major challenge in cancer research. We developed a new fluorescent optical barcoding technique that allows fast tracking, identification, and quantification of live cell clones in vitro and in vivo using flow cytometry (FC). We optically barcoded two cell lines derived from malignant glioma, an exemplary heterogeneous brain tumor. In agreement with mathematical combinatorics, we demonstrate that up to 41 clones can unambiguously be marked using six fluorescent proteins and a maximum of three colors per clone. We show that optical barcoding facilitates sensitive, precise, rapid, and inexpensive analysis of clonal composition kinetics of heterogeneous cell populations by FC. We further assessed the quantitative contribution of multiple clones to glioblastoma growth in vivo and we highlight the potential to recover individual viable cell clones by fluorescence-activated cell sorting. In summary, we demonstrate that optical barcoding is a powerful technique for clonal cell tracking in vitro and in vivo, rendering this approach a potent tool for studying the heterogeneity of complex tissues, in particular, cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biotechnology & Applied Microbiology

Tumor cell E-selectin ligands determine partial efficacy of bortezomib on spontaneous lung metastasis formation of solid human tumors in vivo

Tobias Lange, Ursula Valentiner, Daniel Wicklein, Hanna Maar, Vera Labitzky, Ann-Kristin Ahlers, Sarah Starzonek, Sandra Genduso, Lisa Staffeldt, Carolin Pahlow, Anna-Maria Dueck, Christine Stuerken, Anke Baranowsky, Alexander T. Bauer, Etmar Bulk, Albrecht Schwab, Kristoffer Riecken, Christian Boernchen, Rainer Kiefmann, Valsamma Abraham, Horace M. DeLisser, Timo Gemoll, Jens K. Habermann, Andreas Block, Klaus Pantel, Udo Schumacher

Summary: The proteasome inhibitor bortezomib has been found to impair endothelial adhesion and spontaneous lung metastasis by inhibiting the induction of E-selectin, which is critical for the extravasation of circulating tumor cells. However, the efficacy of bortezomib depends on the specific E-selectin ligands on tumor cells, as low-affinity ligands result in significantly diminished adhesion and lung metastasis. These findings suggest that bortezomib could be used as a drug to inhibit extravasation and distant metastasis in malignancies expressing low-affinity E-selectin ligands.

MOLECULAR THERAPY (2022)

Article Immunology

Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients

Kerri Hagemann, Kristoffer Riecken, Johannes M. Jung, Heike Hildebrandt, Stephan Menzel, Madeleine J. Bunders, Boris Fehse, Friedrich Koch-Nolte, Fabian Heinrich, Sven Peine, Julian Schulze zur Wiesch, Thomas T. Brehm, Marylyn M. Addo, Marc Luetgehetmann, Marcus Altfeld

Summary: In the context of COVID-19, the role of NK cells in the immune response has not been well understood. This study demonstrates that antibodies induced by SARS-CoV-2 infection and anti-SARS-CoV-2 vaccines can activate NK cells, leading to significant immune responses. These findings contribute to a better understanding of the role of NK cells in COVID-19.

EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

Article Oncology

Comparison of single copy gene-based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19-directed CAR T cells in treated patients

Maria-Luisa Schubert, Carolina Berger, Alexander Kunz, Anita Schmitt, Anita Badbaran, Brigitte Neuber, Silke Zeschke, Lei Wang, Kristoffer Riecken, Angela Hueckelhoven-Krauss, Ingo Mueller, Carsten Mueller-Tidow, Peter Dreger, Nicolaus Kroeger, Francis A. Ayuk, Michael Schmitt, Boris Fehse

Summary: The study compared a qPCR assay established at Heidelberg University Hospital in Germany and a digital droplet PCR assay established at University Medical Center Hamburg-Eppendorf in Germany, showing that both independently developed methods enable accurate assessment of CAR T cell frequencies and are useful in the clinical setting.

INTERNATIONAL JOURNAL OF ONCOLOGY (2022)

Article Oncology

Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model

Mohamed Moustafa, Katarzyna-Krystyna Daehling, Armin Guenther, Leonie Riebandt, Daniel J. Smit, Kristoffer Riecken, Carina Schroeder, Ruimeng Zhuang, Till Krech, Malte Kriegs, Boris Fehse, Jakob R. Izbicki, Lutz Fischer, Bjorn Nashan, Jun Li, Manfred Juecker

Summary: This study verifies the impact of targeting CD90 and EpCAM markers in HCC cells with a combination therapy of AKT and mTOR inhibitors. The results demonstrate that combined targeting of AKT and mTOR effectively reduces the proliferation of CD90 and EpCAM positive HCC cells in vitro, but resistance to the treatment occurs in vivo.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Influence of Fetomaternal Microchimerism on Maternal NK Cell Reactivity against the Child's Leukemic Blasts

Lena-Marie Martin, Anne Kruchen, Boris Fehse, Ingo Mueller

Summary: Persistence of fetal cells in the mother's circulation has a beneficial effect on children with leukemia undergoing haploidentical hematopoietic stem cell transplantation. Maternal genetic factors and NK cells play important roles, but cytotoxicity is not solely determined by these factors.

BIOMEDICINES (2022)

Article Medicine, Research & Experimental

High-throughput drug screening allowed identification of entry inhibitors specifically targeting different routes of SARS-CoV-2 Delta and Omicron/BA.1

Maria Kuzikov, Jannis Woens, Andrea Zaliani, Julia Hambach, Thomas Eden, Boris Fehse, Bernhard Ellinger, Kristoffer Riecken

Summary: The study reveals that different SARS-CoV-2 variants of concern (VOCs) have distinct preferences for cell entry, and antagonists of G-protein coupled receptors, such as Chlorpromazine, may exhibit higher activity in inhibiting specific VOCs.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Hematology

Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor T cell therapy

Susanna Carolina Berger, Boris Fehse, Nuray Akyuz, Maria Geffken, Christine Wolschke, Dietlinde Janson, Nico Gagelmann, Marlene Luther, Dominic Wichmann, Christian Frenzel, Guenther Thayssen, Anna Alegiani, Anita Badbaran, Silke Zeschke, Judith Dierlamm, Nicolaus Kroger, Francis A. Ayuk

Summary: CD19-CAR T cell therapy can effectively treat B-cell malignancies, but may cause severe ICANS. The mechanisms of ICANS are not fully understood, and resistance to current therapies has been observed. In this study, we used digital PCR assays to monitor CD19-CAR T cell kinetics in CSF and blood of ICANS patients. We observed CAR T cell enrichment in CSF, even with intense corticosteroid-containing therapies. Longitudinal analysis showed a profound skewing of the T cell repertoire, with expansion of both CAR and non-CAR T cell clones. These findings suggest a role of therapy-refractory T cell clones in severe ICANS and prompt further research on CAR T cells.

HAEMATOLOGICA (2023)

Correction Biochemistry & Molecular Biology

Correction: Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application

Lea Isabell Schwarze, Dawid Glow, Tanja Sonntag, Almut Uhde, Boris Fehse

GENE THERAPY (2023)

Article Immunology

Tissue resident iNKT17 cells facilitate cancer cell extravasation in liver metastasis via interleukin-22

Anastasios D. Giannou, Jan Kempski, Ahmad Mustafa Shiri, Joran Luecke, Tao Zhang, Lilan Zhao, Dimitra E. Zazara, Filippo Cortesi, Kristoffer Riecken, Maria Carolina Amezcua Vesely, Jun Siong Low, Hao Xu, Eleanna Kaffe, Laura Garcia-Perez, Theodora Agalioti, Yoshito Yamada, Wolfgang Jungraithmayr, Ehud Zigmond, Karl-Frederick Karstens, Babett Steglich, Jonas Wagner, Leonie Konczalla, Antonella Carambia, Kornelius Schulze, Johann von Felden, Peter May, Daria Briukhovetska, Tanja Bedke, Leonie Brockmann, Sarah Starzonek, Tobias Lange, Claudia Koch, Sabine Riethdorf, Penelope Pelczar, Marius Boettcher, Morsal Sabihi, Francis J. Huber, Matthias Reeh, Julia Kristin Grass, Ramez Wahib, Hannes Seese, Bjorn-Ole Stueben, Mohammad Fard-Aghaie, Anna Dupree, Pasquale Scognamiglio, Gabriel Plitzko, Jan Meiners, Shiwa Soukou, Agnes Wittek, Caroline Manthey, Ioannis C. Maroulis, Petra C. Arck, Daniel Perez, Bin Gao, Sotirios G. Zarogiannis, Till Strowig, Renata Pasqualini, Wadih Arap, Javier Suarez Gosalvez, Sebastian Kobold, Immo Prinz, Andreas H. Guse, Michael Tachezy, Tarik Ghadban, Asmus Heumann, Jun Li, Nathaniel Melling, Oliver Mann, Jakob R. Izbicki, Klaus Pantel, Udo Schumacher, Ansgar W. Lohse, Richard A. Flavell, Nicola Gagliani, Samuel Huber

Summary: During metastasis, cancer cells go through a series of steps including invasion, intravasation, circulation, extravasation, and colonization of target organs. This study investigated the role of interleukin (IL)-22 in metastasis and found that IL-22 promotes metastasis through its action on endothelial cells and induction of endothelial aminopeptidase N. IL-22-producing iNKT cells were identified as a source of IL-22 and were shown to be tissue resident. Thus, IL-22 may be a potential therapeutic target for preventing metastasis.

IMMUNITY (2023)

Article Biophysics

Spleen volume and length determined by computed tomography impact outcome after allogeneic stem cell transplantation for myelofibrosis

Marlene Luther, Frank Oliver Henes, Tatjana Zabelina, Radwan Massoud, Dietlinde Janson, Christine Wolschke, Evgeny Klyuchnikov, Nico Gagelmann, Boris Fehse, Gerhard Adam, Nicolaus Kroeger, Francis Ayuk

Summary: Splenomegaly is a characteristic of myelofibrosis, and the impact of spleen size on allo-HSCT outcome has been inconsistent due to different assessment methods. A retrospective analysis was conducted on 93 patients, revealing a strong correlation between spleen volume and length. Larger spleen size was associated with slower engraftment and higher risk of disease relapse. In the era of JAK inhibitors, larger spleen size reflects advanced disease and increased risk of relapse, but has no impact on non-relapse mortality and overall survival after allo-HSCT.

BONE MARROW TRANSPLANTATION (2023)

Article Oncology

Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo

Sandra Genduso, Vera Freytag, Daniela Schetler, Lennart Kirchner, Alina Schiecke, Hanna Maar, Daniel Wicklein, Florian Gebauer, Katharina Broeker, Christine Stuerken, Karin Milde-Langosch, Leticia Oliveira-Ferrer, Franz L. Ricklefs, Florian Ewald, Gerrit Wolters-Eisfeld, Kristoffer Riecken, Ludmilla Unrau, Linda Krause, Hanibal Bohnenberger, Anne Offermann, Sven Perner, Susanne Sebens, Katrin Lamszus, Linda Diehl, Stefan Linder, Manfred Juecker, Udo Schumacher, Tobias Lange

Summary: This study analyzed the cooperative effects of ITGB4 and E-/P-selectin in the tumor microenvironment. The results showed that the interaction between ITGB4 and E-/P-selectin promotes tumor growth and attracts MDSCs into the tumor tissue. These findings have important clinical implications for tumor therapy.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2023)

Article Multidisciplinary Sciences

Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer

Joseph Tintelnot, Yang Xu, Till R. Lesker, Martin Schoenlein, Leonie Konczalla, Anastasios D. Giannou, Penelope Pelczar, Dominik Kylies, Victor G. G. Puelles, Agata A. A. Bielecka, Manuela Peschka, Filippo Cortesi, Kristoffer Riecken, Maximilian Jung, Lena Amend, Tobias S. S. Broering, Marija Trajkovic-Arsic, Jens T. T. Siveke, Thomas Renne, Danmei Zhang, Stefan Boeck, Till Strowig, Faik G. G. Uzunoglu, Cenap Gungoer, Alexander Stein, Jakob R. R. Izbicki, Carsten Bokemeyer, Marianne Sinn, Alec C. C. Kimmelman, Samuel Huber, Nicola Gagliani

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with limited response to chemotherapy. Researchers have found that the microbiota-derived metabolite, indole-3-acetic acid (3-IAA), is enriched in patients who respond to treatment. Using a combination of 3-IAA and chemotherapy can improve the efficacy of treatment, providing motivation for considering nutritional interventions in cancer patients.

NATURE (2023)

Article Virology

DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action

Daniela Iaconis, Francesca Caccuri, Candida Manelfi, Carmine Talarico, Antonella Bugatti, Federica Filippini, Alberto Zani, Rubina Novelli, Maria Kuzikov, Bernhard Ellinger, Philip Gribbon, Kristoffer Riecken, Francesca Esposito, Angela Corona, Enzo Tramontano, Andrea Rosario Beccari, Arnaldo Caruso, Marcello Allegretti

Summary: During the COVID-19 pandemic, drug repurposing was an effective strategy in quickly addressing medical emergencies. The anti-viral activity of DHFR inhibitors, including methotrexate, against SARS-CoV-2 was evaluated using cell lines. Results showed that these inhibitors not only had intrinsic anti-metabolic activity but also specific anti-viral functions, making them potential candidates for managing SARS-CoV-2 infection.

VIRUSES-BASEL (2023)

Article Cell Biology

Microglia colonize the developing brain by clonal expansion of highly proliferative progenitors, following allometric scaling

Liam Barry-Carroll, Philip Greulich, Abigail R. Marshall, Kristoffer Riecken, Boris Fehse, Katharine E. Askew, Kaizhen Li, Olga Garaschuk, David A. Menassa, Diego Gomez-Nicola

Summary: Microglia are derived from the yolk sac and migrate into the brain during early embryonic development. They undergo in situ proliferation and ultimately colonize the entire brain by the third postnatal week in mice. This study reveals that their colonization is facilitated by clonal expansion of highly proliferative microglial progenitors distributed throughout the brain. Additionally, the spatial distribution of microglia changes from clustered to random during development.

CELL REPORTS (2023)

Article Biochemistry & Molecular Biology

Deep Characterization and Comparison of Different Retrovirus-like Particles Preloaded with CRISPR/Cas9 RNPs

Max Wichmann, Cecile L. Maire, Niklas Nuppenau, Moataz Habiballa, Almut Uhde, Katharina Kolbe, Tanja Schroeder, Katrin Lamszus, Boris Fehse, Dawid Glow

Summary: The CRISPR/Cas system has potential medical applications, but its clinical translation is hindered by the lack of safe and efficient vector systems. Virus-like particles (VLPs) have been introduced as promising vectors for CRISPR/Cas delivery. In this study, three types of retrovirus-based VLPs were compared, with enhanced egRVLPs showing the most efficient editing and minimal off-target activity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

暂无数据